dactinomycin has been researched along with Pancreatic Neoplasms in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (28.21) | 18.7374 |
1990's | 12 (30.77) | 18.2507 |
2000's | 12 (30.77) | 29.6817 |
2010's | 4 (10.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borrelli, MJ; Crooks, PA; Lamture, G | 1 |
Cheng, Y; Hao, L; Huang, S; Wei, W; Wu, Z | 1 |
Carralot, JP; Liu, XF; Niederfellner, G; Pastan, I; Prunotto, M; Xiang, L; Zhou, Q | 1 |
Bortolotti, C; Fürst, J; Geibel, JP; Hartl, A; Hufnagl, C; Jakab, M; Kunit, T; Langelueddecke, C; Moder, A; Ritter, M; Schmidt, S | 1 |
Erkan, M; Friess, H; Kleeff, J; Pan, Z; Streit, S | 1 |
Li, C; Olberding, KE; Pan, J; Rai, SN; Wang, X; Zhu, Y | 1 |
Alrefai, W; Anderson, KM; Bonomi, P; Dudeja, P; Harris, JE; Hu, Y; Seed, TM | 1 |
LANGDON, EA; OTTOMAN, RE; ROCHLIN, DB; SMART, CR | 1 |
FALKSON, G; SNYMAN, HJ | 1 |
TIMOFEEVSKAIA, EA | 1 |
BOLL, I; KRUECKEMEYER, K | 1 |
Hoffarth, S; Huber, C; Milosevic, J; Schuler, M | 1 |
Adrian, TE; Bell, RH; Bentrem, DJ; Ding, XZ; Fought, AJ; Golkar, L; Kelly, DL; Salabat, MR; Scholtens, D; Talamonti, MS; Ujiki, MB | 1 |
Baba, H; Ishiko, T; Kamohara, H; Ogawa, M; Takahashi, M | 1 |
Fukasawa, M; Korc, M; Matsushita, A | 1 |
Buchanan, KD; Cantwell, B; Collins, PG; Fennelly, JJ; Fielding, JF; FitzGerald, O | 1 |
Fujii, J; Kamada, T; Kaneto, H; Matsuoka, T; Nakamura, M; Seo, HG; Suzuki, K; Taniguchi, N; Tatsumi, H; Yamasaki, Y | 1 |
Egan, JM; Montrose-Rafizadeh, C; Nadiv, O; Raygada, M; Roth, J; Wang, Y | 1 |
Ausiello, DA; Breuer, W; Cabantchik, IZ; Glickstein, H; Kartner, N; Riordan, JR | 1 |
Kuramoto, M; Ogawa, M; Yamashita, J | 1 |
Buchanan, KD; Courtney, MG; Fielding, JF; Holloway, H; Lane, BE; Leavey, SF; Royston, D | 1 |
Dalgleish, AG; Gibson, FM; Gordon-Smith, EC; Marsh, JC; Philpott, NJ; Scopes, J; Turner, AJ; Westby, M | 1 |
Cheng, MY; Lee, AC; Wong, KW | 1 |
Beglinger, C; Eberle, AN; Froidevaux, S; Hintermann, E; Mäcke, HR; Török, M | 1 |
Farrelly, ER; Hirakawa, K; Ho, JJ; Kim, YS; Sowa, M; Yamashita, Y | 1 |
Kleeff, J; Korc, M; Kornmann, M; Sawhney, H | 1 |
Batra, SK; Matsuzaki, H; Picha, KS; Pour, PM; Schmied, BM; Schneider, MB; Standop, J; Ulrich, A | 1 |
Adsay, VN; Glazyrin, AL; Sarkar, FH; Vaitkevicius, VK | 1 |
Adsay, VN; Alhasan, S; Chinni, S; Glazyrin, AL; Sarkar, FH; Vaitkevicius, VK | 1 |
Arimura, GK; Wu, M; Yunis, AA | 1 |
Cubilla, AL; Hajdu, SI | 1 |
Barkin, J; Bateman, J; Brooks, J; Chaffe, J; Douglass, HO; Frytak, S; Hahn, RG; Kalser, M; Knowlton, A; Lavin, PT; Lessner, H; Like, A; Livstone, E; Lokich, J; Mann-Kaplan, R; Milliron, S; Moertel, CG; O'Connell, MJ; Ramming, K; Redlhammer, D; Reitemeier, RJ; Rubin, J; Schein, PS; Schutt, AJ; Silverman, M; Spiro, H; Troner, M; Weiland, LH; Zamcheck, N | 1 |
Chuang, LM; Jou, TS; Lin, BJ; Tai, TY; Wu, HP | 1 |
Bachy, B; Caillaud, JM; Flamant, F; Gruner, M; Hemet, J; Lefur, R; Lemerle, J; Tron, P; Vannier, JP | 1 |
Glinsmann-Gibson, BJ; Korc, M | 1 |
Huang, Y; Hui, DY | 1 |
Arkhipenko, VI; Spitsa, AI | 1 |
Raevskiĭ, IG | 1 |
Connelly, RR; Moldow, RE | 1 |
1 review(s) available for dactinomycin and Pancreatic Neoplasms
Article | Year |
---|---|
Pancreatic vipomas: spectrum of presentation and evolution of diagnostic and therapeutic modalities.
Topics: Combined Modality Therapy; Dactinomycin; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Prednisolone; Vasoactive Intestinal Peptide; Vipoma | 1995 |
2 trial(s) available for dactinomycin and Pancreatic Neoplasms
Article | Year |
---|---|
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group Report.
Topics: Adult; Aged; Bone Marrow; Clinical Trials as Topic; Dactinomycin; Doxorubicin; Drug Evaluation; Female; Humans; Male; Methotrexate; Middle Aged; Pancreatic Neoplasms; Remission, Spontaneous; Time Factors | 1978 |
[A trial of clinical use of the antibiotic chrysomallin].
Topics: Abdominal Muscles; Abdominal Neoplasms; Adult; Antineoplastic Agents; Choriocarcinoma; Clinical Trials as Topic; Dactinomycin; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Pregnancy; Sarcoma; Stomach Neoplasms | 1967 |
36 other study(ies) available for dactinomycin and Pancreatic Neoplasms
Article | Year |
---|---|
Actinomycin-D and dimethylamino-parthenolide synergism in treating human pancreatic cancer cells.
Topics: Aminopyrine; Antibiotics, Antineoplastic; Apoptosis; Dactinomycin; Drug Combinations; Drug Synergism; Growth Inhibitors; Humans; Pancreatic Neoplasms; Tumor Cells, Cultured | 2018 |
Insulin-like growth factor 2 mRNA binding protein 2 promotes aerobic glycolysis and cell proliferation in pancreatic ductal adenocarcinoma via stabilizing GLUT1 mRNA.
Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line; Cell Line, Tumor; Cell Proliferation; Dactinomycin; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Glycolysis; HEK293 Cells; Humans; Kaplan-Meier Estimate; Male; Mice, Nude; Pancreatic Neoplasms; Protein Binding; RNA Interference; RNA-Binding Proteins; RNA, Messenger; RNAi Therapeutics; Xenograft Model Antitumor Assays | 2019 |
Actinomycin D enhances killing of cancer cells by immunotoxin RG7787 through activation of the extrinsic pathway of apoptosis.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dactinomycin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Immunoconjugates; Immunotoxins; Mesothelin; Mice; NF-kappa B; Pancreatic Neoplasms; Xenograft Model Antitumor Assays | 2016 |
The phytostilbene resveratrol induces apoptosis in INS-1E rat insulinoma cells.
Topics: Animals; Apoptosis; Caspases; Cell Cycle; Cell Line, Tumor; Dactinomycin; Insulin; Insulin-Secreting Cells; Insulinoma; Pancreatic Neoplasms; Phosphatidylserines; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; Signal Transduction; Stilbenes; Time Factors | 2009 |
Silencing of GRP94 expression promotes apoptosis in pancreatic cancer cells.
Topics: Apoptosis; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Dactinomycin; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Membrane Glycoproteins; Neoplasm Staging; Nucleic Acid Synthesis Inhibitors; Pancreatic Neoplasms; Prognosis; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Time Factors; Transfection | 2009 |
Actinomycin D synergistically enhances the efficacy of the BH3 mimetic ABT-737 by downregulating Mcl-1 expression.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dactinomycin; Down-Regulation; Drug Synergism; Gene Expression; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Nitrophenols; Pancreatic Neoplasms; Peptide Fragments; Piperazines; Polymerase Chain Reaction; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Sulfonamides | 2010 |
Caspase-dependent and -independent panc-1 cell death due to actinomycin D and MK 886 are additive but increase clonogenic survival.
Topics: Caspases; Cell Death; Cell Division; Cell Survival; Dactinomycin; DNA Damage; DNA Fragmentation; Flow Cytometry; Humans; Indoles; Lipoxygenase Inhibitors; Nucleosomes; Pancreatic Neoplasms; Protein Synthesis Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2003 |
EARLY RESULTS OF COMBINED RADIATION AND CHEMOTHERAPY IN TREATMENT OF MALIGNANT TUMORS.
Topics: Antineoplastic Agents; Colonic Neoplasms; Dactinomycin; Fluorouracil; Humans; Lung Neoplasms; Mitomycin; Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms | 1963 |
EXPERIENCE WITH CHEMOTHERAPY OF CANCER AT THE UNIVERSITY OF PRETORIA.
Topics: Antineoplastic Agents; Aziridines; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Fluorouracil; Hodgkin Disease; Humans; Intestinal Neoplasms; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Mannomustine; Mesothelioma; Multiple Myeloma; Neoplasms; Pancreatic Neoplasms; Sarcoma; South Africa; Stomach Neoplasms; Vinblastine | 1964 |
[COMPARATIVE DATA ON THE EFFECT OF ACTINOMYCIN C AND K ON HUMAN TUMOR CELLS IN TISSUE CULTURE].
Topics: Dactinomycin; Hemangiosarcoma; Kidney Neoplasms; Melanoma; Mesonephroma; Neoplasms; Neoplasms, Experimental; Pancreatic Neoplasms; Pharmacology; Research; Stomach Neoplasms; Tissue Culture Techniques | 1964 |
[ANATOMICAL AND CLINICAL SERIAL OBSERVATIONS IN GIANT FOLLICULAR LYMPHOBLASTOMA (BRILL-SYMMERS DISEASE)].
Topics: Antineoplastic Agents; Biliary Dyskinesia; Dactinomycin; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Pancreatic Neoplasms | 1964 |
The DNA damage-induced decrease of Bcl-2 is secondary to the activation of apoptotic effector caspases.
Topics: Adenocarcinoma; Adenoviridae; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Apoptotic Protease-Activating Factor 1; Caspase Inhibitors; Caspases; Cell Transplantation; Dactinomycin; DNA Damage; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Enzyme Activation; Enzyme Inhibitors; Etoposide; Fibroblasts; Gene Deletion; Humans; Mice; Mice, SCID; Pancreatic Neoplasms; Proteins; Proto-Oncogene Proteins c-bcl-2; Transplantation, Heterologous; Tumor Cells, Cultured; Ultraviolet Rays | 2003 |
Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1.
Topics: Antineoplastic Agents, Phytogenic; Bone Morphogenetic Proteins; Cell Division; Cell Line, Tumor; Dactinomycin; Gene Expression Regulation, Neoplastic; Growth Differentiation Factor 15; Humans; Nucleic Acid Synthesis Inhibitors; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Resveratrol; RNA, Small Interfering; Stilbenes; Transcription, Genetic; Transfection; Up-Regulation | 2007 |
Induction of interleukin-8 (CXCL-8) by tumor necrosis factor-alpha and leukemia inhibitory factor in pancreatic carcinoma cells: Impact of CXCL-8 as an autocrine growth factor.
Topics: Cell Line, Tumor; Cell Proliferation; Cycloheximide; Cytokines; Dactinomycin; Humans; Immunoglobulin G; Inflammation; Intercellular Signaling Peptides and Proteins; Interleukin-8; Leukemia Inhibitory Factor; Pancreatic Neoplasms; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha | 2007 |
Neuropilin-1 interacts with integrin beta1 and modulates pancreatic cancer cell growth, survival and invasion.
Topics: Antibiotics, Antineoplastic; Apoptosis Regulatory Proteins; bcl-X Protein; Caspase 9; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dactinomycin; DNA, Antisense; Humans; Integrin beta1; Neoplasm Invasiveness; Neuropilin-1; Pancreatic Neoplasms; Poly(ADP-ribose) Polymerases; STAT5 Transcription Factor | 2007 |
Metastatic pancreatic vipoma: a case report of clinical response following treatment with corticosteroids and actinomycin D.
Topics: Adenoma, Islet Cell; Dactinomycin; Female; Humans; Indomethacin; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Prednisolone; Vasoactive Intestinal Peptide; Vipoma | 1982 |
Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells.
Topics: Amino Acid Oxidoreductases; Animals; Apoptosis; Cell Survival; Cricetinae; Cycloheximide; Dactinomycin; DNA; Electrophoresis, Agar Gel; Gene Expression; Humans; Insulinoma; Interleukin-1; Islets of Langerhans; Kinetics; Microscopy, Electron, Scanning; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Nucleosomes; Pancreatic Neoplasms; Penicillamine; Rats; Rats, Sprague-Dawley; Recombinant Proteins; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Time Factors; Tumor Cells, Cultured | 1995 |
Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells.
Topics: Animals; Culture Media, Conditioned; Cycloheximide; Dactinomycin; Drug Stability; Drug Synergism; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Transporter Type 1; Hexokinase; Insulin; Insulin Secretion; Insulinoma; Monosaccharide Transport Proteins; Pancreatic Neoplasms; Peptide Fragments; Protein Precursors; Rats; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1995 |
Protein kinase C mediates down-regulation of cystic fibrosis transmembrane conductance regulator levels in epithelial cells.
Topics: Adenocarcinoma; Colonic Neoplasms; Cycloheximide; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dactinomycin; Epithelium; Gene Expression Regulation, Neoplastic; Humans; Indoles; Maleimides; Membrane Proteins; Pancreatic Neoplasms; Protein Biosynthesis; Protein Kinase C; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1993 |
Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells.
Topics: Animals; Aromatase Inhibitors; Binding Sites; Cycloheximide; Dactinomycin; Drug Screening Assays, Antitumor; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Pancreatic Neoplasms; Receptors, Estrogen; Tissue Plasminogen Activator; Toremifene; Tumor Cells, Cultured | 1995 |
The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques.
Topics: Apoptosis; Camptothecin; Carcinoma; Cell Count; Cell Separation; Dactinomycin; DNA Damage; DNA, Neoplasm; Flow Cytometry; Fluorescent Dyes; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Erythroblastic, Acute; Pancreatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Tumor Cells, Cultured | 1996 |
"Response to Hord and Janco re chemotherapy for unresectable pancreatoblastoma".
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Dactinomycin; Drug Resistance, Neoplasm; Fatal Outcome; Follow-Up Studies; Humans; Ifosfamide; Male; Pancreatic Neoplasms; Vincristine | 1997 |
Differential regulation of somatostatin receptor type 2 (sst 2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment.
Topics: Animals; Antineoplastic Agents, Hormonal; Cycloheximide; Dactinomycin; Gene Expression Regulation, Neoplastic; Mice; Mice, SCID; Neoplasm Proteins; Nucleic Acid Synthesis Inhibitors; Octreotide; Pancreatic Neoplasms; Protein Synthesis Inhibitors; Rats; Receptors, Somatostatin; Somatostatin; Tumor Cells, Cultured; Up-Regulation | 1999 |
Forskolin and phorbol ester have opposite effects on the expression of mucin-associated sialyl-Lewis(a) in pancreatic cancer cells.
Topics: Blotting, Western; Colforsin; Cyclic AMP-Dependent Protein Kinases; Dactinomycin; Humans; Mucin-1; Oligosaccharides; Pancreatic Neoplasms; Phorbol Esters; Protein Kinase C; RNA, Messenger; Sialyl Lewis X Antigen; Tumor Cells, Cultured | 2000 |
Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; Carrier Proteins; Cell Division; Dactinomycin; Humans; Pancreatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2000 |
Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and actinomycin D induces apoptosis even in TRAIL-resistant human pancreatic cancer cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Cell Division; Dactinomycin; DNA Primers; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Therapy, Combination; Humans; Immunoenzyme Techniques; In Situ Nick-End Labeling; Ligands; Membrane Glycoproteins; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2001 |
CD95-related apoptotic machinery is functional in pancreatic cancer cells.
Topics: Adenocarcinoma; Apoptosis; Bleomycin; Dactinomycin; Enzyme Activation; fas Receptor; Flow Cytometry; Genes, p53; Humans; Interferon-gamma; Kinetics; Mutation; Paclitaxel; Pancreatic Neoplasms; Peptide Hydrolases; Signal Transduction; Tumor Cells, Cultured | 2001 |
Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Apoptosis; Blotting, Western; Cell Survival; Dactinomycin; Drug Resistance; Electrophoretic Mobility Shift Assay; Enzyme Activation; Enzyme Inhibitors; fas Receptor; Flow Cytometry; Humans; NF-kappa B; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Binding; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Signal Transduction; Tumor Cells, Cultured | 2002 |
Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells.
Topics: Carcinoma; Cells, Cultured; Cycloheximide; Dactinomycin; Hot Temperature; Humans; Hydrogen-Ion Concentration; Isoelectric Point; Molecular Weight; Pancreatic Neoplasms; Plasminogen Activators | 1977 |
Islet cell carcinoma of the pancreas.
Topics: Adenoma, Islet Cell; Adolescent; Adult; Aged; Child; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Hyperglycemia; Hypoglycemia; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Pancreas; Pancreatic Neoplasms; Streptozocin | 1975 |
Inhibitory effect of islet amyloid polypeptide of glucose-induced proinsulin biosynthesis in rat insulinoma cells.
Topics: Amyloid; Animals; Dactinomycin; Dose-Response Relationship, Drug; Glucose; Insulinoma; Islet Amyloid Polypeptide; Islets of Langerhans; Pancreatic Neoplasms; Proinsulin; Rats; Tumor Cells, Cultured | 1992 |
Pancreatoblastoma: response to chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Vinblastine; Vincristine | 1991 |
Regulation of transforming growth factor-alpha mRNA expression in T3M4 human pancreatic carcinoma cells.
Topics: Dactinomycin; Epidermal Growth Factor; Gene Expression Regulation, Neoplastic; Humans; Nucleic Acid Hybridization; Pancreatic Neoplasms; RNA, Messenger; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Transforming Growth Factor alpha; Tumor Cells, Cultured | 1991 |
Cholesterol esterase biosynthesis in rat pancreatic AR42J cells. Post-transcriptional activation by gastric hormones.
Topics: Animals; Cell Line; Cholecystokinin; Dactinomycin; Enzyme Activation; Enzyme Induction; Kinetics; Molecular Weight; Pancreatic Neoplasms; Protein Biosynthesis; Rats; RNA, Neoplasm; Secretin; Sterol Esterase | 1991 |
[The effect of hormones and actinomycin on tumor cell multiplication in in vitro experiments].
Topics: Antibiotics, Antineoplastic; Carcinoma; Dactinomycin; Female; Flavonoids; In Vitro Techniques; Insulin; Neoplasm Transplantation; Ovarian Neoplasms; Pancreatic Neoplasms; Thyroxine | 1971 |
Epidemiology of pancreatic cancer in Connecticut.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Black People; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Connecticut; Cystadenocarcinoma; Dactinomycin; Family Characteristics; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Nitrogen Mustard Compounds; Pancreatic Neoplasms; Prognosis; Religion; Residence Characteristics; Seasons; Sex Factors; Thiotepa; White People | 1968 |